UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Understand when to scale your business for growth. Timing is crucial for success—find out the best moments to expand effectively.
25,932 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Elon Musk's X Money expands beyond beta, raising new questions about Bitcoin's future. Analysts weigh whether private...
Oilfield services stocks led by Baker Hughes, Halliburton, and Transocean each rose around 5% as crude oil prices jum...
Gold and silver slid this week as geopolitical risk and higher oil costs pressured bullion, while Bitcoin bucked the ...
Scotiabank boosted Cameco's price target to $175 as a global push for nuclear power gains traction and a new supply d...
Ethereum is the lone red stake among the top-10 cryptos this week, while Bitcoin and other large caps post gains as i...
Graduates at several universities faced boos as speakers praised AI, even as the same cohort leans on AI tools for st...
As SpaceX moves toward a historic public listing, Antonio Gracias could see his private stake surge into the tens of ...
Solana faces a pivotal test as investors weigh upgrade catalysts, institutional interest, and the memory of a memecoi...
Mortgage lenders are navigating a regulatory minefield as AI-generated marketing enters the mortgage space. New rules...
SpaceX’s IPO priced at $135 per share, raising $75 billion and signaling a landmark moment for tokenized equities as ...
Two executive actions aim to accelerate quantum tech and prepare for encryption threats, sparking a rally in quantum-...